Literature DB >> 22296359

Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group.

Surapon Wiangnon1, Gavivann Veerakul, Issarang Nuchprayoon, Panya Seksarn, Suradej Hongeng, Triroj Krutvecho, Nintita Sripaiboonkij.   

Abstract

BACKGROUND: Previous population-based incidences of childhood cancer in Thailand were achieved by extrapolating from data limited to a small number of cancer registries, not from the whole country. In addition, survival of childhood cancer patients is often described in specialized hospitals and/or institutions, but not in the general population.
METHODS: All children aged 0-15 years who were newly diagnosed as having cancer were registered from 18 treatment centers during 2003-5 and classified into 12 diagnostic groups according to the International Classification of Childhood Cancer. Incidences were calculated by a standard method and survival was investigated using the ThaiPOG (Thai Pediatric Oncology Group) population-based registration data. Overall survival was calculated by the Kaplan Meier method.
RESULTS: In the study period (2003-5) 2,792 newly diagnosed cases of childhood cancer were registered, with mean and median ages of 6.5 (SD=0.13) and 5.0 (0-14) years, respectively. The age-peak was between 1 and 4 years and the age-standardized rate (ASR) was 74.9 per million. Leukemia was the most common cancer (N=1421, ASR 38.1) followed by lymphoma (N=266, ASR 6.4) and neoplasms of the central nervous system (CNS, N=246, ASR 6.3). The follow-up duration totaled 101,250 months. The death rate was 1.11 per 100 person-months (95%CI: 1.02 -1.20). The 5-year overall survival was 54.9% (95%CI: 53.0%-56.9%) for all cancers. The respective, 5-year overall survival for (1) acute lymphoblastic leukemia (ALL), (2) acute non-lymphoblastic leukemia (ANLL), (3) lymphoma, (4) retinoblastoma, (5) renal tumors, (6) liver tumors, (7) germ cell tumors, (8) CNS tumors, (9) neuroblastoma, (10) soft tissue tumors and (11) bone tumors were (1) 64.5%, (2) 35.1%, (3) 59.5%, (4) 73.1%, (5) 70.4%, (6) 44.5%, (7) 70.6%, (8) 41.7%, (9) 33.6%, (10) 50.1%, and (11) 33.7%.
CONCLUSIONS: The incidence of childhood cancer is lower than in western countries. Respective overall survival for ALL, lymphoma, renal tumors, liver tumors, retinoblastoma, soft tissue tumors is lower than those reported in developed countries while for CNS tumors, neuroblastoma and germ cell tumors the figures are comparable.

Entities:  

Mesh:

Year:  2011        PMID: 22296359

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  16 in total

1.  Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes.

Authors:  Bunchoo Pongtanakul; Nongnuch Sirachainan; Pacharapan Surapolchai; Pimlak Charoenkwan; Worawut Choeyprasert; Patcharee Komwilaisak; Su-On Chainansamit; Nittaya Witsanuyothin; Yujinda Lertrakul; Piya Rujkijyanont; Somjai Kanjanapongkul; Darintr Sosothikul; Kleebsabai Sanpakit; Thirachit Chotsampancharoen; Somporn Wangruangsathit; Nintita Sripaiboonkij Thokanit; Sommaphun Tabjareon; Suradej Hongeng
Journal:  J Neurooncol       Date:  2020-07-24       Impact factor: 4.130

2.  Differences in childhood leukemia incidence and survival between Southern Thailand and the United States: a population-based analysis.

Authors:  Kathryn Demanelis; Hutcha Sriplung; Rafael Meza; Surapon Wiangnon; Laura S Rozek; Michael E Scheurer; Philip J Lupo
Journal:  Pediatr Blood Cancer       Date:  2015-05-11       Impact factor: 3.167

3.  Correlation between clinical presentations, radiological findings and high risk histopathological features of primary enucleated eyes with advanced retinoblastoma at Queen Sirikit National Institute of Child Health: 5 years result.

Authors:  Supawan Surukrattanaskul; Bungornrat Keyurapan; Nutsuchar Wangtiraumnuay
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

4.  Acute kidney injury and childhood acute myeloid leukemia.

Authors:  Chompoonut Limratchapong; Praewa Sophark; Prayong Vachvanichsanong; Edward B McNeil; Thirachit Chotsampancharoen
Journal:  Pediatr Nephrol       Date:  2022-03-07       Impact factor: 3.651

5.  Characteristics and trends in incidence of childhood cancer in Beijing, China, 2000-2009.

Authors:  Lei Yang; Yannan Yuan; Tingting Sun; Huichao Li; Ning Wang
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

6.  Childhood cancer incidence and survival in Thailand: A comprehensive population-based registry analysis, 1990-2011.

Authors:  Serena S Bidwell; Catherine C Peterson; Kathryn Demanelis; Katie R Zarins; Rafael Meza; Hutcha Sriplung; Surapon Wiangnon; Thirachit Chotsampancharoen; Imjai Chitapanarux; Donsuk Pongnikorn; Karnchana Daoprasert; Krittika Suwanrungruang; Wasan Chansaard; Laura S Rozek
Journal:  Pediatr Blood Cancer       Date:  2018-08-31       Impact factor: 3.167

7.  Predictors of Chemotherapy Induced Adverse Events in Pediatric Osteosarcoma Patients.

Authors:  Phitjira Sanguanboonyaphong; Patcharee Komvilaisak; Kunanya Suwannaying; Jukapun Yoodee; Manit Saeteaw; Suthan Chanthawong; Suphat Subongkot
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

8.  Improvement of treatment outcome over 2 decades in children with acute myeloid leukemia.

Authors:  Tae Yang Song; Sang Hoon Lee; Gun Kim; Hee Jo Baek; Tai Ju Hwang; Hoon Kook
Journal:  Blood Res       Date:  2018-03-27

Review 9.  Retinoblastoma in Asia.

Authors:  Mukesh Jain; Duangnate Rojanaporn; Bhavna Chawla; Gangadhar Sundar; Lingam Gopal; Vikas Khetan
Journal:  Eye (Lond)       Date:  2018-11-01       Impact factor: 3.775

10.  Incidence and Survival of Childhood Cancer in Korea.

Authors:  Hyeon Jin Park; Eun-Kyeong Moon; Ju Young Yoon; Chang-Mo Oh; Kyu-Won Jung; Byung Kiu Park; Hee Young Shin; Young-Joo Won
Journal:  Cancer Res Treat       Date:  2016-01-21       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.